acucela inc (4589:Tokyo Stock Exchange)
Peter A. Kresel M.B.A
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
Mr. Peter Kresel M.B.A. served as Senior Vice President of Global Regulatory Affairs at Allergan. Mr. Kresel facilitated the movement of new products through various regulatory agencies. This includes extremely successful products such as BOTOX, Alphagan and Lumigan, as well as products with difficult regulatory profiles, such as tazarotene. Mr. Kresel served as Scientific Advisor of Acucela Inc. Prior to Allergan, he was the Director of Worldwide Regulatory Affairs ...
1301 Second AvenuePhone: 206-805-8300
Seattle, Washington 98101
Board Members Memberships*There is no Board Members Memberships data available.
Other Affiliations*There is no Company Affiliations data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.